Shuang-Jia Wang

3PUBLICATIONS
6CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 02, 2024
Efficacy and Safety of Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Inhibitors for Hepatocellular Carcinoma Patients with Extrahepatic Metastases: A Multicenter Retrospective Study.

De-Yi Liu, Yi-Nan Li, Jia-Yi Wu

|Sep 30, 2024
Impact of Duration of Adjuvant Therapy on Patients with Initially Unresectable Hepatocellular Carcinoma After Conversion Surgery: A Propensity Score Matching Study.

Zhong-Tai Lin, Shao-Ming Wei, Jun-Yi Wu

|Oct 22, 2021
Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study.

Jia-Yi Wu, Zhen-Yu Yin, Yan-Nan Bai

Pageof 1

Frequent Collaborators

2 joint publications

Jian-Yin Zhou

2 joint publications

Zhen-Xin Zeng

2 joint publications

Yang-Kai Fu

2 joint publications

Jia-Yi Wu